Tag: deep vein thrombosis market outlook

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

How Will the Deep Vein Thrombosis Market Grow from 2024 to 2033?

In recent times, there has been a steady increase in the size of the deep vein thrombosis market. The market will expand from a value of $1.03 billion in 2023 to $1.07 billion in 2024, growing at a Compound Annual Growth Rate (CAGR) of 4.5%. The growth observed during the historically significant period is due to factors such as greater specialization in vascular medicine, the impact of medical guidelines, an emphasis on preventing thrombosis, advancements in clinical research, and heightened awareness around diagnosis.

The market size of deep vein thrombosis is anticipated to experience consistent expansion in the forthcoming years, reaching $1.26 billion by 2028 and progressing at a compound annual growth rate (CAGR) of 4.1%. The predicted growth during the forecast period is due to factors such as the increasing elderly population, emergence of lifestyle diseases, a heightened focus on preventive healthcare, innovative treatment methods, and a shift towards patient-oriented care. Key trends during the forecast period encompass heightened consciousness about risk factors, diagnostic advancements, novel treatment strategies, public health campaigns, and post-operation prevention.

Claim Your Free Sample of the Global Deep Vein Thrombosis Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=10616&type=smp

What Aspects Are Influencing the Growth Rate of the deep vein thrombosis Market?

The surge in the population requiring treatment for deep vein thrombosis (DVT) foreshadows the expansion of the deep vein thrombosis market in the future. Treating deep vein thrombosis involves using drugs such as anticoagulants among others to deter the formation of new blood clots and to prevent existing ones from expanding, thereby reducing the disease symptoms. There is a rise in the number of patients needing DVT treatment, suggestive of the growing prevalence of deep vein thrombosis necessitating products for its diagnosis, prevention, and treatment. For example, the Centers for Disease Control and Prevention (CDC), a US-based national public health body, stated in February 2023 that approximately 900,000 people could be impacted annually in the United States by deep vein thrombosis and between 60,000 to 100,000 Americans die annually due to DVT or PE (pulmonary embolism). Hence, the growing population requiring deep vein thrombosis (DVT) treatment contributes to the market’s growth.

What Are the Critical Segments of the Deep Vein Thrombosis Market?

1) By Drug Class: Anticoagulants, Inferior Vena Cava Filters, Other Drug Class

2) By Treatment: Surgery, Drugs, Other Treatments

3) By Mode Of Administration: Injectable, Oral, Other Modes Of Action

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End User: Hospitals, Homecare, Specialty Clinics, Other End-users

What Trends Are Redefining Consumer Expectations in the Deep Vein Thrombosis Market?

The trend of product innovations is increasingly making waves in the deep vein thrombosis market. Firms heavily engaged in this market are leveraging the latest technologies to craft new products and retain their market prominence. For instance, Penumbra Inc., a United States-based creator of cutting-edge therapies, unveiled Lightning Flash in January 2023. This sophisticated, formidable mechanical thrombectomy system tackles venous and pulmonary thrombus. It’s equipped with Penumbra’s groundbreaking lightning-intelligent aspiration technology and dual clot detection algorithms. This system has been engineered to expediently eliminate extensive blood clots in the body, such as venous thrombus and pulmonary emboli (PE). It equips doctors with a high torque-able and larger catheter that’s ideal for efficiently eradicating substantial clot burdens in the pulmonary arteries or deep venous system, upholding an excellent safety record concurrently.

Order Now for Fast Delivery of Your Deep Vein Thrombosis Market Report!

https://www.thebusinessresearchcompany.com/report/deep-vein-thrombosis-global-market-report

What Are the Leading Regions in the Deep Vein Thrombosis Market Expansion?

North America was the largest region in the deep vein thrombosis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global deep vein thrombosis market report during the forecast period. The regions covered in the deep vein thrombosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Deep Vein Thrombosis Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the deep vein thrombosis market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Deep Vein Thrombosis Market Include

1. Deep Vein Thrombosis Market Executive Summary

2. Deep Vein Thrombosis Market Segments

3. Deep Vein Thrombosis Market Size And Template Market Growth Rate

4. Key Deep Vein Thrombosis Market Trends

5. Major Deep Vein Thrombosis Market Drivers

……

25. Key Mergers And Acquisitions In The Deep Vein Thrombosis Market

26. Top Deep Vein Thrombosis Companies

27. Deep Vein Thrombosis Market Opportunities And Strategies

28. Deep Vein Thrombosis Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Stem Cell/Cord Blood Banking Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report

Wearable Blood Pressure Monitors Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/wearable-blood-pressure-monitors-global-market-report

Defense Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/defense-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Deep Vein Thrombosis Global Market Report 2024, the deep vein thrombosis market is expected to show significant growth in the forecast period.

Understanding the Growth Trajectory

The deep vein thrombosis market has witnessed a steady increase in size over recent years, with notable projections for the future:

• The market size surged from $1.03 billion in 2023 to $1.07 billion in 2024, representing a compound annual growth rate (CAGR) of 4.5%.
• Predictions indicate further growth, reaching $1.26 billion in 2028, with a CAGR of 4.1%.
• The historic and forecasted growth stems from various factors, including increased specialization in vascular medicine, adherence to medical guidelines, and a heightened focus on thrombosis prevention.

Rising Demand for DVT Treatment Drives Market Growth

The escalating need for deep vein thrombosis (DVT) treatment serves as a significant catalyst for market expansion:

• DVT treatment involves administering drugs such as anticoagulants to prevent the formation and enlargement of blood clots.
• According to the Centers for Disease Control and Prevention (CDC), DVT affects an estimated 900,000 individuals annually in the United States, with up to 100,000 fatalities attributed to DVT or PE.
• Key players in the market, including Abbott Laboratories and Bristol-Myers Squibb Company, are actively engaged in addressing this demand through product development and innovation.

View More On The Deep Vein Thrombosis Market Report 2024 – https://www.thebusinessresearchcompany.com/report/deep-vein-thrombosis-global-market-report

Revolutionary Innovations in Mechanical Thrombectomy Systems

Product innovation emerges as a pivotal trend shaping the landscape of the deep vein thrombosis market:

• Companies like Penumbra Inc. are introducing cutting-edge technologies to enhance thrombectomy systems.
• Penumbra’s Lightning Flash technology, unveiled in January 2023, represents a significant advancement in mechanical thrombectomy, offering dual clot detection algorithms and intelligent aspiration capabilities.
• Surmodics’ strategic acquisition of Vetex Medical in July 2021 underscores the industry’s commitment to expanding thrombectomy portfolios and bolstering market presence.

Segmentation and Geographic Insights

Understanding the deep vein thrombosis market necessitates a closer look at its segmentation and regional dynamics:

1. Segmentation: The market is segmented by drug class, treatment, mode of administration, distribution channel, and end-user, offering comprehensive insights into its multifaceted nature.
2. Regional Trends: North America emerged as the largest region in the deep vein thrombosis market in 2023, while Asia-Pacific is poised to witness the fastest growth during the forecast period.

Embracing Opportunities and Challenges Ahead

As the deep vein thrombosis market continues to evolve, it presents both opportunities and challenges:

• Opportunities: Aging populations, increasing incidence of lifestyle diseases, and a growing emphasis on preventive healthcare fuel market growth.
• Challenges: Regulatory complexities, healthcare infrastructure disparities, and the need for sustainable innovation pose notable challenges to market stakeholders.

Conclusion

The deep vein thrombosis market stands at the forefront of medical innovation, driven by a convergence of technological advancements, demographic shifts, and evolving healthcare landscapes. As companies strive to address unmet medical needs and improve patient outcomes, the market is poised for continued expansion and transformation in the years ahead. By leveraging emerging trends and fostering collaboration across stakeholders, we can unlock the full potential of the deep vein thrombosis market and usher in a new era of healthcare excellence.

Request A Sample Of The Global Deep Vein Thrombosis Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=10616&type=smp